Tag: Jeffery Archer
In recent months, the world has watched as an international hero and celebrated champion confessed to using performance-enhancing drugs in all seven of his Tour de France victories.
Lance Armstrong’s rise to global fame began after a well-documented battle with testicular cancer in 1996 and 1997. His story captivated the world, and his consecutive Tour de France victories from 1999–2005 made him one of the most remarkable figures of perseverance and success in sports history.
His victory over cancer led to the creation of the Livestrong Foundation in 1997. The Livestrong Foundation benefited greatly from Mr. Armstrong’s widespread popularity and has since raised over half a billion dollars for cancer patients and their families.
While Mr. Armstrong garnered unbridled support from millions of people around the world, he was dogged by many who doubted his extraordinary success. In 2004, David Walsh, the chief sports writer for U.K. Newspaper The Sunday Times, and Pierre Ballester published “L.A. Confidentiel,” a book containing numerous allegations about Mr. Armstrong’s use of performance-enhancing drugs.
In June 2004, the Times published an article that referenced the book and its doping allegations. In response, Mr. Armstrong sued the newspaper for libel in the United Kingdom. The parties reached a settlement in 2006. As part of the settlement, the Times released a public statement: “The Sunday Times has confirmed to Mr. Armstrong that it never intended to accuse him of being guilty of taking any performance enhancing drugs and sincerely apologized for any such impression.”
On December 23, 2012, Velo News reported that the Times is suing Mr. Armstrong to recover the money paid in the 2006 settlement, plus interest and legal fees. The article explains that after Mr. Armstrong was stripped of his seven Tour de France titles in October 2012, the Times decided to pursue the lawsuit against Mr. Armstrong to recover the money that it had paid for, it turns out, stating the truth.
LASIS will explore further…